Press release
FDA Releases Draft Guidance on CMC For Individualized ASO Therapies
SAE Media Group proudly presents the return of the Oligonucleotide Therapeutics & Delivery Conference on the 21st and 22nd September 2022 in London, UK. The two-day conference will bring you high-quality insights and industry connections on the latest clinical trial candidates and a platform for exchanging ideas for tackling the biggest challenge: DELIVERY.Personalized medicine continues to be at the cutting edge of healthcare, pharmaceuticals, and biotechnology. For patients afflicted with a unique disease state or those with diseases resistant or inadequately treated by existing therapies, personalized treatments are a last, best hope.
However, for pharmaceutical companies, the safe and ethical development of individualized treatments is, as with any new pharmaceutical, an expensive and time-intensive endeavor. This creates a conflict between the need for these therapies and the lack of a large patient population that may participate in clinical trials and ultimately purchase an approved treatment to offset the initial development costs.
This issue was recognised by the FDA and on December 7th, 2021, a new draft guidance was published: "IND Submissions For Individualized Antisense Oligonucleotide Drug Products For Severely Debilitating Or Life-Threatening Diseases: Chemistry, Manufacturing, And Controls Recommendations, Guidance For Sponsor-Investigators.1"*
The CMC Guidance entails:
•difficulties inherent in manufacturing these individualized treatments
•in turn it offers research and manufacturers the opportunity to create policies and procedures that are more likely to be condoned by the FDA in an IND submission
Presenting on this in more detail at the conference will be Chris Chorley, Associate Director, Global Regulatory CMC from Biogen who will speak about "Current CMC Regulatory Challenges In ASO Development" and Sergio Leone, Research Associate, MRC Toxicology Unit from University of Cambridge who will be presenting on "Molecular Mechanisms Of Antisense Oligonucleotide Cytotoxicity".
Chris Chorley's presentation will be touching on:
•Overview of key CMC regulatory challenges during the clinical development phase
•Regulatory strategies for use of platform data and prior knowledge
Sergio Leone's presentation will be touching on:
•Introduction to the mechanistic action of ASOs in cells after delivery
•Insight into in vivo and in vitro models for the study of ASO cytotoxicity
•Exploring molecular mechanisms of ASO cytotoxicity to better design future ASO therapeutics
•Discussion of balancing safety and efficacy of ASOs
There will also be two pre-conference workshops on 20th September 2022 in London UK.
The first workshop will be discussing "Oligonucleotide Therapies- Overcoming The Challenges Of Delivery" led by Ritwick Sawakar, MRC Investigator, MRC Toxcology Unit, University Of Cambridge, Nick Lench, Executive Director, UKRI/MRC Nucleic Acid Therapy (NATA) and Peter Oliver, Head of Biology, UKRI/MRC Nucleic Acid Therapy (NATA).
The second workshop will be focused on "Managing CMC Activities For The Development Of Oligonucleotide Therapeutics" and this will be led by Mia Kiistala, Principal Consultant, Aurora CMC Consulting.
Interested parties can register for the conference and workshop at: http://www.oligonucleotide.co.uk
For sponsorship opportunities, please contact Andrew Gibbons on +44 (0) 20 7827 6156 or email: agibbons@smi-online.co.uk
For media enquiries or a press pass contact Marketing, Nikisha Galoria on +44 (0) 20 7827 6154 or email ngaloria@smi-online.co.uk
2nd Annual Oligonucleotide Therapeutics & Delivery Conference
21-22 September 2022
London, UK
Sponsors & Exhibitors: Catalent | ChemGenes | NOF Corporation | Wuxi App Tech
http://www.oligonucleotide.co.uk
Source*: http://www.cellandgene.com
India House, 45 Curlew Street
---------- END ----------
About SAE Media Group Conferences:
SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com
SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release FDA Releases Draft Guidance on CMC For Individualized ASO Therapies here
News-ID: 2674958 • Views: …
More Releases from SAE Media Group

Launch of the C-UAS Hub Report 2025: Countering the Threat: A Comprehensive Revi …
SAE Media Group, renowned for its sell-out Counter UAS Conferences and owner of the C-UAS Hub, is excited to announce the release of its first-ever C-UAS Hub Report 2025, titled "Countering the Threat: A Comprehensive Review of National C-UAS Programs."
As drones continue to play an increasingly prominent role in both military and civilian sectors, the demand for effective Counter UAS solutions is growing rapidly. NATO allies are making significant investments…

How MilSatCom has transformed warfare and continues to shape the battlefield.
The advancement of space-based communications technologies, including the ever-increasing presence of military satellites for electronic and signals intelligence purposes, has dramatically changed the way wars are fought down on Earth.
From the launch of the first satellite communications network to the cutting-edge technology that is still in development, below we take a look at how far MilSatCom has come.
A brief history of MilSatCom
The first military communications satellites were launched by the…

Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture
SAE Media Group reports: Conference co-chairs invite delegates to join the anticipated 6th Annual 3D Cell Culture Conference
SAE Media Group is delighted to announce the return of successful 3D Cell Culture Conference for its 6th year, taking place on 8 and 9 February 2023 in London, UK.
The 2023 Conference theme is on exploring the implementation of complex in-vitro models for drug development
Visit the website at http://www.3d-cellculture.com/PR2 to find out…

Exploring the Implementation of Complex In-vitro Models for Drug Development
SAE Media Group reports: Agenda and speaker overview released for the 6th Annual 3D Cell Culture Conference, London, UK
SAE Media Group is delighted to announce the return of successful 3D Cell Culture Conference for its 6th year, taking place on 8 and 9 February 2023 in London, UK.
3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to…
More Releases for Oligonucleotide
Oligonucleotide Synthesis Market CAGR 9.9% by 2035, Due To The Growing Demand Fo …
According to our latest market report "Oligonucleotide Synthesis Market by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-users, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the global oligonucleotide synthesis market size is projected to reach USD 13.5 billion by 2035 from USD 4.8 billion in 2024, growing at a CAGR of 9.9% in the forecast period…
Oligonucleotide Synthesis Market Outlook, 2030
The global oligonucleotide synthesis market is set to witness unprecedented growth in the coming decade, driven by advancements in biotechnology, increasing applications in genetic research, and rising demand for personalized medicine. According to market research, the global oligonucleotide synthesis market size was valued at USD 5.198 billion in 2020 and is projected to reach USD 26.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.10% from…
Antisense Oligonucleotide Therapeutics Market
Antisense Oligonucleotide Therapeutics Market worth $ 64.64 Billion by 2030 - Exclusive Report by Insight Analytics
Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Antisense Oligonucleotide Therapeutics Market- by Therapy (Monotherapy and Combination), Molecule Target Indication (DNA Molecule and RNA Molecule), Target Indication (Duchenne Muscular Atrophy, Spinal Muscular Atrophy, Familial Chylomicronemia Syndrome, Amyotrophic Lateral Sclerosis, Familial Partial Lipodystrophy, Hereditary Transthyretin-Mediated (hatter) Amyloidosis, Huntington's Disease…
Oligonucleotide Therapy Market Transforming Healthcare: The Oligonucleotide Ther …
Oligonucleotide Therapy Market worth $19.92 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oligonucleotide Therapy Market - (By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User
(Hospitals, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According…
Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthes …
Researchmoz added latest report "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis…
Oligonucleotide Synthesis Market 2017 Development Trends
This report studies the global Oligonucleotide Synthesis market, analyzes and researches the Oligonucleotide Synthesis development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Agilent Technologies
Biosearch Technologies
Eurofins Genomics
Eurogentec
Integrated DNA Technologies
Merck KGAA
Thermo Fisher Scientific
GeneDesign
Bio-Synthesis - CRO/CMO Life Sciences Company
Bioautomation
GE Healthcare
LGC Biosearch Technologies
NITTO Denko Avecia
For more information about this report at http://www.reportsweb.com/global-oligonucleotide-synthesis-market-size-status-and-forecast-2022
Market segment by Regions/Countries, this report…